Invention Grant
- Patent Title: Phosphatidylserine targeting fusion molecules and methods for their use
-
Application No.: US16631961Application Date: 2018-07-24
-
Publication No.: US11352404B2Publication Date: 2022-06-07
- Inventor: Sergei V. Kotenko , Raymond B. Birge , Viralkumar Rameshkumar Davra
- Applicant: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
- Applicant Address: US NJ New Brunswick
- Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
- Current Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
- Current Assignee Address: US NJ New Brunswick
- Agency: Licata & Tyrrell P.C.
- International Application: PCT/US2018/043357 WO 20180724
- International Announcement: WO2019/023156 WO 20190131
- Main IPC: C07K19/00
- IPC: C07K19/00 ; C07K14/555 ; A61P35/00 ; C07K14/71 ; A61K38/00
Abstract:
Fusion molecules of a cytokine or portion thereof and a polypeptide which targets the fusion protein to phosphatidylserine, pharmaceutical compositions thereof, and methods for their use in targeting a cytokine or portion thereof to a pathological site and treating a disease or condition responsive to cytokine treatment are provided.
Public/Granted literature
- US20200181221A1 PHOSPHATIDYLSERINE TARGETING FUSION MOLECULES AND METHODS FOR THEIR USE Public/Granted day:2020-06-11
Information query
